AYTU – Aytu BioPharma, Inc.
Float Short %
5.62
Margin Of Safety %
Put/Call OI Ratio
EPS Next Q Diff
0.98
EPS Last/This Y
0.57
EPS This/Next Y
1.76
Price
2.3
Target Price
9.33
Analyst Recom
1
Performance Q
13.86
Upside
-5,943.5%
Beta
0.37
Ticker: AYTU
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-01-23 | AYTU | 2.68 | N/A | N/A | 0 |
| 2026-01-26 | AYTU | 2.74 | N/A | N/A | 0 |
| 2026-01-27 | AYTU | 2.61 | N/A | N/A | 0 |
| 2026-01-28 | AYTU | 2.61 | N/A | N/A | 0 |
| 2026-01-29 | AYTU | 2.58 | N/A | N/A | 0 |
| 2026-01-30 | AYTU | 2.625 | N/A | N/A | 0 |
| 2026-02-02 | AYTU | 2.73 | N/A | N/A | 0 |
| 2026-02-03 | AYTU | 2.63 | N/A | N/A | 0 |
| 2026-02-04 | AYTU | 2.37 | N/A | N/A | 0 |
| 2026-02-05 | AYTU | 2.29 | N/A | N/A | 0 |
| 2026-02-06 | AYTU | 2.45 | N/A | N/A | 0 |
| 2026-02-09 | AYTU | 2.29 | N/A | N/A | 0 |
| 2026-02-10 | AYTU | 2.29 | N/A | N/A | 0 |
| 2026-02-11 | AYTU | 2.29 | N/A | N/A | 0 |
| 2026-02-12 | AYTU | 2.19 | N/A | N/A | 0 |
| 2026-02-13 | AYTU | 2.16 | N/A | N/A | 0 |
| 2026-02-17 | AYTU | 2.18 | N/A | N/A | 0 |
| 2026-02-18 | AYTU | 2.32 | N/A | N/A | 0 |
| 2026-02-19 | AYTU | 2.35 | N/A | N/A | 0 |
| 2026-02-20 | AYTU | 2.3 | N/A | N/A | 0 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-01-23 | AYTU | 2.70 | - | - | -0.81 |
| 2026-01-26 | AYTU | 2.74 | - | - | -0.70 |
| 2026-01-27 | AYTU | 2.60 | - | - | -0.70 |
| 2026-01-28 | AYTU | 2.60 | - | - | -0.70 |
| 2026-01-29 | AYTU | 2.59 | - | - | -0.70 |
| 2026-01-30 | AYTU | 2.60 | - | - | -0.70 |
| 2026-02-02 | AYTU | 2.74 | - | - | -0.70 |
| 2026-02-03 | AYTU | 2.65 | - | - | -0.70 |
| 2026-02-04 | AYTU | 2.35 | - | - | -0.70 |
| 2026-02-05 | AYTU | 2.30 | - | - | -0.70 |
| 2026-02-06 | AYTU | 2.43 | - | - | -0.70 |
| 2026-02-09 | AYTU | 2.30 | - | - | -1.27 |
| 2026-02-10 | AYTU | 2.30 | - | - | -1.27 |
| 2026-02-11 | AYTU | 2.32 | - | - | -1.27 |
| 2026-02-12 | AYTU | 2.18 | - | - | -1.27 |
| 2026-02-13 | AYTU | 2.14 | - | - | -1.59 |
| 2026-02-17 | AYTU | 2.18 | - | - | -1.59 |
| 2026-02-18 | AYTU | 2.32 | - | - | -1.59 |
| 2026-02-19 | AYTU | 2.29 | - | - | -1.59 |
| 2026-02-20 | AYTU | 2.30 | - | - | -1.59 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-01-23 | AYTU | 0.00 | 1.20 | 5.55 |
| 2026-01-26 | AYTU | 0.00 | 2.23 | 5.55 |
| 2026-01-27 | AYTU | 0.00 | 2.23 | 5.55 |
| 2026-01-28 | AYTU | 0.00 | 2.23 | 5.87 |
| 2026-01-29 | AYTU | 0.00 | 2.23 | 5.87 |
| 2026-01-30 | AYTU | 0.00 | 2.23 | 5.87 |
| 2026-02-02 | AYTU | 0.00 | 2.76 | 5.87 |
| 2026-02-03 | AYTU | 0.00 | 2.76 | 5.87 |
| 2026-02-04 | AYTU | 0.00 | 2.76 | 5.87 |
| 2026-02-05 | AYTU | 0.00 | 2.76 | 5.87 |
| 2026-02-06 | AYTU | 0.00 | 2.76 | 5.57 |
| 2026-02-09 | AYTU | 0.00 | -1.00 | 5.57 |
| 2026-02-10 | AYTU | 0.00 | -1.00 | 5.57 |
| 2026-02-11 | AYTU | 0.00 | -1.00 | 5.62 |
| 2026-02-12 | AYTU | 0.00 | -1.00 | 5.62 |
| 2026-02-13 | AYTU | 0.00 | -1.00 | 5.62 |
| 2026-02-17 | AYTU | 0.00 | 7.74 | 5.62 |
| 2026-02-18 | AYTU | 0.00 | 7.74 | 5.62 |
| 2026-02-19 | AYTU | 0.00 | 7.74 | 5.62 |
| 2026-02-20 | AYTU | 0.00 | 7.74 | 5.62 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-1.05
Avg. EPS Est. Current Quarter
-0.65
Avg. EPS Est. Next Quarter
-0.07
Insider Transactions
Institutional Transactions
7.74
Beta
0.37
Average Sales Estimate Current Quarter
13
Average Sales Estimate Next Quarter
15
Fair Value
Quality Score
32
Growth Score
33
Sentiment Score
70
Actual DrawDown %
99
Max Drawdown 5-Year %
-99.5
Target Price
9.33
P/E
Forward P/E
PEG
P/S
0.39
P/B
1.74
P/Free Cash Flow
EPS
-3.84
Average EPS Est. Cur. Y
-1.59
EPS Next Y. (Est.)
0.17
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-39.02
Relative Volume
0.15
Return on Equity vs Sector %
-201.1
Return on Equity vs Industry %
-179.3
EPS 1 7Days Diff
-0.9
EPS 1 30Days Diff
-0.78
EBIT Estimation
Aytu BioPharma, Inc.Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees: 82
Aytu BioPharma, Inc., a pharmaceutical company, focuses on commercializing novel therapeutics in the United States and internationally. The company offers prescription products for the treatment of attention deficit hyperactivity disorder (ADHD), including Adzenys XR-ODT extended-release orally disintegrating tablets for patients from six years of age and above; Cotempla XR-ODT extended-release orally disintegrating tablets for patients from six to seventeen years old; and Metadate CD, a central nervous system stimulant indicated for the treatment of ADHD. It also provides pediatric prescription product portfolio comprising Karbinal ER, an extended-release carbinoxamine (antihistamine) suspension indicated to treat numerous allergic conditions for patients two years and above; and Poly-Vi-Flor and Tri-Vi-Flor complementary prescription fluoride-based multi-vitamin products containing combinations of fluoride and vitamins in liquid and chewable tablet form for infants and children with fluoride deficiency. The company was formerly known as Aytu BioScience, Inc. and changed its name to Aytu BioPharma, Inc. in March 2021. Aytu BioPharma, Inc. is headquartered in Denver, Colorado.
stock quote shares AYTU – Aytu BioPharma, Inc. Stock Price stock today
news today AYTU – Aytu BioPharma, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch AYTU – Aytu BioPharma, Inc. yahoo finance google finance
stock history AYTU – Aytu BioPharma, Inc. invest stock market
stock prices AYTU premarket after hours
ticker AYTU fair value insiders trading